Loading…
2 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Vakis-Parki | Fitness & Wellness | 13.4% | 57th pct | 30 |
| In-Si | Construction | 3.2% | 29th pct | 582 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2024 | In-Si | Vakis-Parki |
|---|---|---|
| Margins | ||
| Gross Margin | 8.9% | 66.0% |
| EBITDA Margin | 3.2% | 13.4% |
| EBITDAR | 2,541 | 106 |
| EBITDAR Margin | 3.3% | 13.4% |
| EBIT Margin | 2.4% | 13.4% |
| Net Profit Margin | -0.4% | -22.9% |
| Operating Expense % of Sales | 5.7% | 52.6% |
| Returns | ||
| Return on Assets (ROA) | -0.3% | -5.8% |
| Return on Equity (ROE) | N/A | N/A |
| ROIC [EBIT / Invested Capital] | N/A | 5.1% |
| Leverage & debt balances | ||
| Debt-to-Assets | 7.9% | 88.9% |
| Debt-to-Equity | -0.73x | -4.07x |
| Debt-to-EBITDA | 3.11x | 26.00x |
| Equity-to-Assets | -10.8% | -21.8% |
| Net Debt | 6,537 | 2,753 |
| Cash & Equivalents | 1,119 | 13 |
| Total Debt | 7,656 | 2,767 |
| Liquidity & working capital | ||
| Current Ratio | 1.56x | 0.05x |
| Quick Ratio | 1.31x | 0.05x |
| Cash Ratio | 0.03x | 0.01x |
| Total Current Assets | 54,412 | 80 |
| Total Current Liabilities | 34,904 | 1,593 |
| Inventory | 8,732 | N/A |
| Trade Receivables | 12,502 | 44 |
| Trade Payables | 6,827 | 998 |
| Net Working Capital | 19,508 | -1,513 |
| Net Working Capital % of Revenue | 25.6% | -191.0% |
| Trade Working Capital | 14,407 | -954 |
| Trade Working Capital % of Revenue | 18.9% | -120.4% |
| Change in Trade Working Capital | N/A | N/A |
| Turnover & efficiency | ||
| Inventory Turnover | 7.94x | N/A |
| Days Inventory Outstanding (DIO) | 46.0 | N/A |
| Receivables Turnover | 6.09x | 18.16x |
| Days Sales Outstanding (DSO) | 60.0 | 20.1 |
| Payables Turnover | 10.15x | 0.27x |
| Days Payable Outstanding (DPO) | 36.0 | 1351.6 |
| Cash Conversion Cycle | 70.0 days | -1331.6 days |
| Asset Turnover | 0.78x | 0.25x |
| Cash flow & dividends | ||
| Operating Cash Flow | 6,160 | 243 |
| Free Cash Flow (OCF − Capex proxy) | 5,103 | 243 |
| Cash Conversion (OCF / EBITDA) | 250.3% | 228.3% |
| Dividends Declared | 0 | N/A |
| Dividend Payout Ratio | N/A | N/A |